annual accounts payable:
$1.91B+$318.00M(+20.00%)Summary
- As of today (May 23, 2025), AMGN annual accounts payable is $1.91 billion, with the most recent change of +$318.00 million (+20.00%) on December 31, 2024.
- During the last 3 years, AMGN annual accounts payable has risen by +$542.00 million (+39.68%).
- AMGN annual accounts payable is now at all-time high.
Performance
AMGN Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$2.41B+$498.00M(+26.10%)Summary
- As of today (May 23, 2025), AMGN quarterly accounts payable is $2.41 billion, with the most recent change of +$498.00 million (+26.10%) on March 31, 2025.
- Over the past year, AMGN quarterly accounts payable has increased by +$778.00 million (+47.79%).
- AMGN quarterly accounts payable is now at all-time high.
Performance
AMGN quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
AMGN Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +20.0% | +47.8% |
| 3 y3 years | +39.7% | +71.5% |
| 5 y5 years | +39.2% | +79.8% |
AMGN Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +39.7% | at high | +99.8% |
| 5 y | 5-year | at high | +39.7% | at high | +109.2% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
AMGN Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $2.41B(+26.1%) |
| Dec 2024 | $1.91B(+20.0%) | $1.91B(-11.1%) |
| Sep 2024 | - | $2.15B(-5.3%) |
| Jun 2024 | - | $2.27B(+39.3%) |
| Mar 2024 | - | $1.63B(+2.4%) |
| Dec 2023 | $1.59B(+1.1%) | $1.59B(+17.1%) |
| Sep 2023 | - | $1.36B(+12.0%) |
| Jun 2023 | - | $1.21B(-8.2%) |
| Mar 2023 | - | $1.32B(-16.0%) |
| Dec 2022 | $1.57B(+15.1%) | $1.57B(+30.6%) |
| Sep 2022 | - | $1.20B(-4.1%) |
| Jun 2022 | - | $1.26B(-10.5%) |
| Mar 2022 | - | $1.40B(+2.7%) |
| Dec 2021 | $1.37B(-3.9%) | $1.37B(+16.7%) |
| Sep 2021 | - | $1.17B(-8.3%) |
| Jun 2021 | - | $1.28B(-8.5%) |
| Mar 2021 | - | $1.40B(-1.8%) |
| Dec 2020 | $1.42B(+3.6%) | $1.42B(+22.4%) |
| Sep 2020 | - | $1.16B(+1.0%) |
| Jun 2020 | - | $1.15B(-14.1%) |
| Mar 2020 | - | $1.34B(-2.4%) |
| Dec 2019 | $1.37B(+13.6%) | $1.37B(+36.4%) |
| Sep 2019 | - | $1.00B(+0.4%) |
| Jun 2019 | - | $1.00B(-8.2%) |
| Mar 2019 | - | $1.09B(-9.6%) |
| Dec 2018 | $1.21B(-10.7%) | $1.21B(+15.8%) |
| Sep 2018 | - | $1.04B(+1.6%) |
| Jun 2018 | - | $1.03B(-5.8%) |
| Mar 2018 | - | $1.09B(-19.5%) |
| Dec 2017 | $1.35B(+47.4%) | $1.35B(+53.8%) |
| Sep 2017 | - | $879.00M(-0.5%) |
| Jun 2017 | - | $883.00M(-2.1%) |
| Mar 2017 | - | $902.00M(-1.6%) |
| Dec 2016 | $917.00M(-5.0%) | $917.00M(+11.2%) |
| Sep 2016 | - | $825.00M(-5.2%) |
| Jun 2016 | - | $870.00M(+6.4%) |
| Mar 2016 | - | $818.00M(-15.2%) |
| Dec 2015 | $965.00M(-3.0%) | $965.00M(-9.6%) |
| Sep 2015 | - | $1.07B(+14.2%) |
| Jun 2015 | - | $934.00M(+5.2%) |
| Mar 2015 | - | $888.00M(-10.8%) |
| Dec 2014 | $995.00M(+26.4%) | $995.00M(+4.2%) |
| Sep 2014 | - | $955.00M(-2.7%) |
| Jun 2014 | - | $982.00M(+3.5%) |
| Mar 2014 | - | $949.00M(+20.6%) |
| Dec 2013 | $787.00M(-13.0%) | $787.00M(-12.1%) |
| Sep 2013 | - | $895.00M(-11.0%) |
| Jun 2013 | - | $1.01B(+7.0%) |
| Mar 2013 | - | $940.00M(+3.9%) |
| Dec 2012 | $905.00M(+41.0%) | $905.00M(+3.1%) |
| Sep 2012 | - | $878.00M(-0.7%) |
| Jun 2012 | - | $884.00M(-0.8%) |
| Mar 2012 | - | $891.00M(+38.8%) |
| Dec 2011 | $642.00M(-10.3%) | $642.00M(-12.5%) |
| Sep 2011 | - | $734.00M(-15.6%) |
| Jun 2011 | - | $870.00M(+4.6%) |
| Mar 2011 | - | $832.00M(+16.2%) |
| Dec 2010 | $716.00M(+24.7%) | $716.00M(-0.8%) |
| Jun 2010 | - | $722.00M(-18.1%) |
| Mar 2010 | - | $882.00M(+53.7%) |
| Dec 2009 | $574.00M(+13.9%) | $574.00M(-6.4%) |
| Sep 2009 | - | $613.00M(-3.5%) |
| Jun 2009 | - | $635.00M(-7.6%) |
| Mar 2009 | - | $687.00M(+36.3%) |
| Dec 2008 | $504.00M(+33.3%) | $504.00M(-6.3%) |
| Sep 2008 | - | $538.00M(-29.6%) |
| Jun 2008 | - | $764.00M(+46.4%) |
| Mar 2008 | - | $522.00M(+38.1%) |
| Dec 2007 | $378.00M(-31.9%) | $378.00M(-13.7%) |
| Sep 2007 | - | $438.00M(-19.2%) |
| Jun 2007 | - | $542.00M(-9.8%) |
| Mar 2007 | - | $601.00M(+8.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $555.00M(-6.9%) | $555.00M(-2.5%) |
| Sep 2006 | - | $569.00M(-14.8%) |
| Jun 2006 | - | $668.00M(+51.1%) |
| Mar 2006 | - | $442.00M(-25.8%) |
| Dec 2005 | $596.00M(+17.6%) | $596.00M(+19.9%) |
| Sep 2005 | - | $497.00M(-1.2%) |
| Jun 2005 | - | $503.00M(-8.4%) |
| Mar 2005 | - | $549.00M(+8.3%) |
| Dec 2004 | $507.00M(+55.0%) | $507.00M(+50.4%) |
| Sep 2004 | - | $337.00M(+8.0%) |
| Jun 2004 | - | $311.90M(+0.3%) |
| Mar 2004 | - | $311.00M(-4.9%) |
| Dec 2003 | $327.00M(+28.2%) | $327.00M(+29.0%) |
| Sep 2003 | - | $253.40M(-6.1%) |
| Jun 2003 | - | $270.00M(-7.5%) |
| Mar 2003 | - | $291.80M(+14.4%) |
| Dec 2002 | $255.00M(+86.5%) | $255.00M(+29.0%) |
| Sep 2002 | - | $197.70M(+49.3%) |
| Jun 2002 | - | $132.40M(+24.8%) |
| Mar 2002 | - | $106.10M(-22.4%) |
| Dec 2001 | $136.70M(-4.5%) | $136.70M(+94.5%) |
| Sep 2001 | - | $70.30M(-27.9%) |
| Jun 2001 | - | $97.50M(+0.6%) |
| Mar 2001 | - | $96.90M(-32.3%) |
| Dec 2000 | $143.20M(+71.7%) | $143.20M(+17.8%) |
| Sep 2000 | - | $121.60M(+1.2%) |
| Jun 2000 | - | $120.10M(+10.5%) |
| Mar 2000 | - | $108.70M(+30.3%) |
| Dec 1999 | $83.40M(-31.4%) | $83.40M(-17.3%) |
| Sep 1999 | - | $100.80M(-30.0%) |
| Jun 1999 | - | $144.00M(+51.4%) |
| Mar 1999 | - | $95.10M(-21.8%) |
| Dec 1998 | $121.60M(+17.0%) | $121.60M(+39.3%) |
| Sep 1998 | - | $87.30M(+2.7%) |
| Jun 1998 | - | $85.00M(-26.0%) |
| Mar 1998 | - | $114.80M(+10.5%) |
| Dec 1997 | $103.90M(+38.5%) | $103.90M(+45.3%) |
| Sep 1997 | - | $71.50M(-13.4%) |
| Jun 1997 | - | $82.60M(+7.8%) |
| Mar 1997 | - | $76.60M(+2.1%) |
| Dec 1996 | $75.00M(+37.9%) | $75.00M(+79.9%) |
| Sep 1996 | - | $41.70M(-21.3%) |
| Jun 1996 | - | $53.00M(+65.6%) |
| Mar 1996 | - | $32.00M(-41.2%) |
| Dec 1995 | $54.40M(+78.4%) | $54.40M(+15.3%) |
| Sep 1995 | - | $47.20M(+23.9%) |
| Jun 1995 | - | $38.10M(+13.7%) |
| Mar 1995 | - | $33.50M(+9.8%) |
| Dec 1994 | $30.50M(+32.0%) | $30.50M(+39.3%) |
| Sep 1994 | - | $21.90M(+28.8%) |
| Jun 1994 | - | $17.00M(-17.9%) |
| Mar 1994 | - | $20.70M(-10.4%) |
| Dec 1993 | $23.10M(-39.2%) | $23.10M(+9.5%) |
| Sep 1993 | - | $21.10M(-21.3%) |
| Jun 1993 | - | $26.80M(+16.0%) |
| Mar 1993 | - | $23.10M(-39.2%) |
| Dec 1992 | $38.00M(+28.8%) | $38.00M(+59.0%) |
| Sep 1992 | - | $23.90M(-2.4%) |
| Jun 1992 | - | $24.50M(-0.8%) |
| Mar 1992 | - | $24.70M(-16.3%) |
| Dec 1991 | $29.50M(+48.2%) | $29.50M(+150.0%) |
| Sep 1991 | - | $11.80M(-19.2%) |
| Jun 1991 | - | $14.60M(-26.6%) |
| Mar 1991 | - | $19.90M(+168.9%) |
| Mar 1991 | $19.90M(+65.8%) | - |
| Dec 1990 | - | $7.40M(-21.3%) |
| Sep 1990 | - | $9.40M(+74.1%) |
| Jun 1990 | - | $5.40M(-55.0%) |
| Mar 1990 | $12.00M(+41.2%) | $12.00M(+76.5%) |
| Dec 1989 | - | $6.80M(+51.1%) |
| Sep 1989 | - | $4.50M(-28.6%) |
| Jun 1989 | - | $6.30M(-25.9%) |
| Mar 1989 | $8.50M | $8.50M |
FAQ
- What is Amgen annual accounts payable?
- What is the all time high annual accounts payable for Amgen?
- What is Amgen annual accounts payable year-on-year change?
- What is Amgen quarterly accounts payable?
- What is the all time high quarterly accounts payable for Amgen?
- What is Amgen quarterly accounts payable year-on-year change?
What is Amgen annual accounts payable?
The current annual accounts payable of AMGN is $1.91B
What is the all time high annual accounts payable for Amgen?
Amgen all-time high annual accounts payable is $1.91B
What is Amgen annual accounts payable year-on-year change?
Over the past year, AMGN annual accounts payable has changed by +$318.00M (+20.00%)
What is Amgen quarterly accounts payable?
The current quarterly accounts payable of AMGN is $2.41B
What is the all time high quarterly accounts payable for Amgen?
Amgen all-time high quarterly accounts payable is $2.41B
What is Amgen quarterly accounts payable year-on-year change?
Over the past year, AMGN quarterly accounts payable has changed by +$778.00M (+47.79%)